{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T14:54:03Z","timestamp":1761749643279,"version":"build-2065373602"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,29]]},"DOI":"10.7759\/cureus.95670","type":"journal-article","created":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T14:50:43Z","timestamp":1761749443000},"source":"Crossref","is-referenced-by-count":0,"title":["A Case Report and Literature Review: When Should We Treat the Seminal Vesicles in Prostate Cancer?"],"prefix":"10.7759","author":[{"given":"Rohail","family":"Syed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nitin","family":"Vaishampayan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramesh","family":"Boggula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Joiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongping","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven R","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"American Cancer Society. Key statistics for prostate cancer. (2024).  https.\/\/www.cancer.org\/cancer\/types\/prostate-cancer\/about\/key-statistics.html."},{"key":"ref2","unstructured":"Prostate Cancer Research Institute. Side effects from radiation therapy. (2024). Accessed. April 16, 2025: https:\/\/pcri.org\/azure-1\/2017\/9\/18\/side-effects-from-radiation-therapy."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15133402","article-title":"The impact of PSMA PET\/CT on modern prostate cancer management and decision making\u2014the urological perspective","volume":"15","author":"Hoffman A","year":"2023","unstructured":"Hoffman A, Amiel GE. The impact of PSMA PET\/CT on modern prostate cancer management and decision making\u2014the urological perspective. Cancers (Basel). 2023, 15:3402. 10.3390\/cancers15133402","journal-title":"Cancers (Basel)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2018.01.014","article-title":"ESTRO ACROP consensus guideline on CT- and MRI-based target volume delineation for primary radiation therapy of localized prostate cancer","volume":"127","author":"Salembier C","year":"2018","unstructured":"Salembier C, Villeirs G, De Bari B, et al.. ESTRO ACROP consensus guideline on CT- and MRI-based target volume delineation for primary radiation therapy of localized prostate cancer. Radiother Oncol. 2018, 127:49-61. 10.1016\/j.radonc.2018.01.014","journal-title":"Radiother Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/s0360-3016(02)03011-0","article-title":"Treatment of prostate cancer with radiotherapy: should the entire seminal vesicles be included in the clinical target volume?","volume":"54","author":"Kestin L","year":"2002","unstructured":"Kestin L, Goldstein N, Vicini F, Yan D, Korman H, Martinez A. Treatment of prostate cancer with radiotherapy: should the entire seminal vesicles be included in the clinical target volume?. Int J Radiat Oncol Biol Phys. 2002, 54:686-97. 10.1016\/s0360-3016(02)03011-0","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.clon.2007.03.005","article-title":"When should the seminal vesicles be included in the target volume in prostate radiotherapy?","volume":"19","author":"Bayman NA","year":"2007","unstructured":"Bayman NA, Wylie JP. When should the seminal vesicles be included in the target volume in prostate radiotherapy?. Clin Oncol (R Coll Radiol). 2007, 19:302-7. 10.1016\/j.clon.2007.03.005","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/curroncol30070483","article-title":"Seminal vesicle treatment for localized prostate cancer treated with external beam radiotherapy","volume":"30","author":"Steed T","year":"2023","unstructured":"Steed T, Chopra N, Yun J, et al.. Seminal vesicle treatment for localized prostate cancer treated with external beam radiotherapy. Curr Oncol. 2023, 30:6587-95. 10.3390\/curroncol30070483","journal-title":"Curr Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2023.03.001","article-title":"Head-to-head comparison of the diagnostic accuracy of prostate-specific membrane antigen positron emission tomography and conventional imaging modalities for initial staging of intermediate- to high-risk prostate cancer: a systematic review and meta-analysis","volume":"84","author":"Chow KM","year":"2023","unstructured":"Chow KM, So WZ, Lee HJ, et al.. Head-to-head comparison of the diagnostic accuracy of prostate-specific membrane antigen positron emission tomography and conventional imaging modalities for initial staging of intermediate- to high-risk prostate cancer: a systematic review and meta-analysis. Eur Urol. 2023, 84:36-48. 10.1016\/j.eururo.2023.03.001","journal-title":"Eur Urol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2021.08.002","article-title":"The additive diagnostic value of prostate-specific membrane antigen positron emission tomography computed tomography to multiparametric magnetic resonance imaging triage in the diagnosis of prostate cancer (PRIMARY): a prospective multicentre study","volume":"80","author":"Emmett L","year":"2021","unstructured":"Emmett L, Buteau J, Papa N, et al.. The additive diagnostic value of prostate-specific membrane antigen positron emission tomography computed tomography to multiparametric magnetic resonance imaging triage in the diagnosis of prostate cancer (PRIMARY): a prospective multicentre study. Eur Urol. 2021, 80:682-9. 10.1016\/j.eururo.2021.08.002","journal-title":"Eur Urol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2024.109249","article-title":"Role of [18F]-PSMA-1007 PET radiomics for seminal vesicle invasion prediction in primary prostate cancer","volume":"183","author":"Luo L","year":"2024","unstructured":"Luo L, Wang X, Xie H, et al.. Role of [18F]-PSMA-1007 PET radiomics for seminal vesicle invasion prediction in primary prostate cancer. Comput Biol Med. 2024, 183:109249. 10.1016\/j.compbiomed.2024.109249","journal-title":"Comput Biol Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/379015-a-case-report-and-literature-review-when-should-we-treat-the-seminal-vesicles-in-prostate-cancer","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T14:50:47Z","timestamp":1761749447000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/379015-a-case-report-and-literature-review-when-should-we-treat-the-seminal-vesicles-in-prostate-cancer"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,29]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.95670","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,29]]}}}